A comparison of ebastine 10 mg fast-dissolving tablet with oral desloratadine and placebo in inhibiting the cutaneous reaction to histamine in healthy adults (Q28305881)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A comparison of ebastine 10 mg fast-dissolving tablet with oral desloratadine and placebo in inhibiting the cutaneous reaction to histamine in healthy adults	scientific article

Statements

scholarly article

0 references

A comparison of ebastine 10 mg fast-dissolving tablet with oral desloratadine and placebo in inhibiting the cutaneous reaction to histamine in healthy adults (English)

0 references

0 references

Rosa Maria Antonijoan

1

object named as

Rosa M Antonijoan

0 references

author name string

Consuelo García-Gea

2

0 references

Montserrat Puntes

3

0 references

Marta Valle

4

0 references

Ramon Esbri

5

0 references

Josep Fortea

6

0 references

Manuel J Barbanoj

7

0 references

language of work or name

0 references

publication date

2007

0 references

Clinical Drug Investigation

0 references

27

0 references

7

0 references

453-61

0 references

The pharmacokinetics, antihistamine and concentration-effect relationship of ebastine in healthy subjects

1 reference

https://api.crossref.org/works/10.2165%2F00044011-200727070-00002

21 January 2018

Ebastine: an update of its use in allergic disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/17563125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/17563125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A study comparing the inhibitory effects of single and repeated oral doses of ebastine and fexofenadine against histamine-induced skin reactivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17563125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Appraisal of the validity of histamine-induced wheal and flare to predict the clinical efficacy of antihistamines

1 reference

https://pubmed.ncbi.nlm.nih.gov/17563125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, single-dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine versus placebo: suppression of histamine-induced wheal and flare response for 24 h in healthy male subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/17563125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval

1 reference

https://pubmed.ncbi.nlm.nih.gov/17563125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Skin test reactivity to histamine from infancy to old age

1 reference

https://pubmed.ncbi.nlm.nih.gov/17563125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, placebo-controlled study of the efficacy and safety of ebastine 20 mg once daily given with and without food in the treatment of seasonal allergic rhinitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17563125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of skin pigmentation on the response to intradermal histamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/17563125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the effects of desloratadine and levocetirizine on histamine-induced wheal, flare and itch in human skin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17563125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of ebastine, cetirizine, and loratadine in histamine cutaneous challenges

1 reference

https://pubmed.ncbi.nlm.nih.gov/17563125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical studies of the efficacy and tolerability of ebastine 10 or 20 mg once daily in the treatment of seasonal allergic rhinitis in the US

1 reference

https://pubmed.ncbi.nlm.nih.gov/17563125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ebastine in perennial allergic rhinitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17563125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind multicentre comparative study of ebastine, terfenadine and placebo in the treatment of chronic idiopathic urticaria in adults.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17563125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis. The Ebastine Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17563125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of ebastine in the control of nasal congestion associated with allergic rhinitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17563125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of ebastine to cetirizine in seasonal allergic rhinitis in adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/17563125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis of the efficacy of ebastine 20 mg compared to loratadine 10 mg and placebo in the symptomatic treatment of seasonal allergic rhinitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17563125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 12-week, placebo-controlled study of the efficacy and safety of ebastine, 10 and 20 mg once daily, in the treatment of perennial allergic rhinitis. Multicentre Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17563125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of ebastine (10 and 20 mg) and cetirizine at 24 hours of a steady state treatment in the skin of healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/17563125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of ebastine (20 mg and 10 mg) to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17563125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval

1 reference

https://pubmed.ncbi.nlm.nih.gov/17563125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and safety of ebastine in patients with impaired hepatic function compared with healthy volunteers: a phase I open-label study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17563125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Central and peripheral evaluation of rupatadine, a new antihistamine/platelet-activating factor antagonist, at different doses in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/17563125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic-pharmacodynamic relationships of H1-antihistamines

1 reference

https://pubmed.ncbi.nlm.nih.gov/17563125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A review of the second-generation antihistamine ebastine for the treatment of allergic disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/17563125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of ebastine 20 mg compared to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17563125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00044011-200727070-00002

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28305881&oldid=1671341927"